Results 241 to 250 of about 58,205 (308)

Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer

open access: yesInternational Journal of Urology, Volume 33, Issue 1, January 2026.
ABSTRACT Objectives Considering the high frequency of intravesical recurrence in bladder urothelial carcinoma (UBC), accurate non‐invasive biomarkers for recurrence prediction are needed for better management after transurethral surgery. This pilot study examined the usefulness of urine DNA for detecting and predicting intravesical recurrence in UBC ...
Masashi Shiozaki   +6 more
wiley   +1 more source

Improving radiomics-based isocitrate dehydrogenase 1 prediction in glioma patients using semi-supervised machine learning models. [PDF]

open access: yesBMC Med Imaging
Ahmadzadeh AM   +5 more
europepmc   +1 more source

Supplemental Table 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia

open access: gold
Amir T. Fathi   +21 more
openalex   +1 more source

Peripheral Blood Leukocyte Ratios as Novel Biomarkers in Brain Glioma: A Comprehensive Systematic Review and Meta‐Analysis

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 1, January 2026.
ABSTRACT Inflammatory biomarkers, such as leukocyte ratios, have emerged as promising tools for diagnosing and prognosticating brain gliomas. This study systematically reviewed and analysed the diagnostic and prognostic relevance of peripheral blood leukocyte ratios in glioma.
Fatemeh Hasani   +12 more
wiley   +1 more source

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? [PDF]

open access: yesJ Gastrointest Cancer
Barsch M   +3 more
europepmc   +1 more source

Integrative Bioinformatics Reveals Novel Molecular Mechanisms and Therapeutic Targets in Acute Myeloid Leukaemia

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 1, January 2026.
ABSTRACT Acute myeloid leukaemia (AML) is a genetically heterogeneous malignancy associated with poor prognosis and limited treatment options. To identify molecular programs conserved across AML subtypes and perturbations, we analysed three RNA sequencing datasets that captured venetoclax treatment under metabolic stress and the knockdown of chromatin ...
Muteb Muyey Daniel, Gradel Holel Andwey
wiley   +1 more source

Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors. [PDF]

open access: yesInt J Mol Sci
Nikitsenka K   +9 more
europepmc   +1 more source

Oxidative Phosphorylation in Silent Pituitary Adenomas: A Multiomics Perspective

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Although the World Health Organization has clearly defined silent pituitary adenomas (SPAs) and functional adenomas (non‐SPAs), the detailed biological mechanisms remain unclear. This study conducted a comprehensive analysis of clinical, genomic, transcriptomic, and proteomic differences between SPA and non‐SPA.
Yuan Chen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy